Amrize (NYSE:AMRZ) Issues Earnings Results

Amrize (NYSE:AMRZ) issued its quarterly earnings results on Wednesday. The company reported $1.05 earnings per share (EPS) for the quarter, FiscalAI reports. Amrize had a net margin of 9.89% and a return on equity of 10.22%. The firm had revenue of $3.77 billion for the quarter.

Amrize Stock Performance

AMRZ stock traded down $0.15 during midday trading on Wednesday, reaching $40.08. 7,310,328 shares of the company were exchanged, compared to its average volume of 3,408,560. Amrize has a one year low of $35.78 and a one year high of $65.94. The firm has a market capitalization of $22.17 billion, a price-to-earnings ratio of 18.47, a price-to-earnings-growth ratio of 1.40 and a beta of 0.20. The business has a 50-day moving average price of $39.95 and a two-hundred day moving average price of $50.83. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73.

Amrize Announces Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize’s payout ratio is 5.07%.

Analyst Ratings Changes

Several analysts recently issued reports on AMRZ shares. Truist Financial dropped their target price on Amrize from $48.00 to $35.00 and set a “hold” rating on the stock in a report on Monday, October 5th. JPMorgan Chase & Co. lowered their price target on Amrize from $52.00 to $48.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 13th. Royal Bank Of Canada dropped their price objective on Amrize from $48.00 to $32.00 and set an “underperform” rating on the stock in a research note on Friday, October 9th. Stephens dropped their price target on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 12th. Finally, DA Davidson set a $40.00 target price on shares of Amrize in a research note on Friday, October 9th. Eight investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $49.12.

Insider Buying and Selling

In related news, Director Jacques Sanche bought 4,150 shares of the business’s stock in a transaction dated Wednesday, August 26th. The stock was bought at an average price of $45.02 per share, for a total transaction of $186,833.00. Following the purchase, the director owned 9,766 shares in the company, valued at $439,665.32. This represents a 73.90% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jan Jenisch bought 26,000 shares of the business’s stock in a transaction dated Wednesday, September 2nd. The shares were bought at an average price of $42.47 per share, with a total value of $1,104,220.00. Following the purchase, the chief executive officer owned 1,767,000 shares in the company, valued at $75,044,490. The trade was a 1.49% increase in their position. The SEC filing for this purchase provides additional information. Over the last three months, insiders purchased 48,983 shares of company stock valued at $2,158,755. 0.54% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Amrize

Institutional investors have recently made changes to their positions in the company. Allspring Global Investments Holdings LLC lifted its holdings in Amrize by 3.7% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company’s stock worth $263,371,000 after purchasing an additional 171,622 shares during the last quarter. Renaissance Technologies LLC grew its holdings in Amrize by 10.4% in the 1st quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company’s stock valued at $109,609,000 after buying an additional 183,900 shares in the last quarter. Amundi increased its position in Amrize by 30.9% during the 1st quarter. Amundi now owns 1,654,739 shares of the company’s stock worth $92,698,000 after buying an additional 390,750 shares during the period. Swiss National Bank increased its position in Amrize by 7.1% during the 1st quarter. Swiss National Bank now owns 1,460,874 shares of the company’s stock worth $81,838,000 after buying an additional 96,800 shares during the period. Finally, National Pension Service increased its position in Amrize by 7.5% during the 2nd quarter. National Pension Service now owns 1,493,022 shares of the company’s stock worth $79,578,000 after buying an additional 103,962 shares during the period.

Amrize Company Profile

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.